Blind Biopsy Can Miss Diagnoses and
May Add to Treatment Delays

In the evaluation of abnormal uterine bleeding (AUB), blind biopsy alone can miss diagnoses of up to 18% of patients and may add to treatment delays.

If cancer occupies less than 50%

Cancer can be missed by a blind EMB

of the surface area of the endometrial cavity, the cancer can be missed by a blind biopsy1

Blind biopsy alone could miss the diagnosis of focal lesions in

Blind biopsy alone of AUB can miss the diagnosis of 18% of patients

up to 18% of patients2

Use Direct Visualization at Point-of-Care

In premenopausal ovulatory women with AUB,
hysteroscopy will detect an anatomical structural lesion

Hysteroscopy will detect an anatomical structural lesion in 65-80% of patients

in 65-80% of patients3

Diagnose More Accurately

Endosee allows you to diagnose uterine focal pathology more accurately than endometrial biopsy alone.

Sensitivity for diagnosing polyps1

Blind Biopsy 11%
Hysteroscopy 89%
  • 0
  • 10
  • 20
  • 30
  • 40
  • 50
  • 60
  • 70
  • 80
  • 90
  • 100

Sensitivity for diagnosing myomas1

Blind Biopsy 13%
Hysteroscopy 100%
  • 0
  • 10
  • 20
  • 30
  • 40
  • 50
  • 60
  • 70
  • 80
  • 90
  • 100

Sensitivity for diagnosing hyperplasia1

Blind Biopsy 25%
Hysteroscopy 74%
  • 0
  • 10
  • 20
  • 30
  • 40
  • 50
  • 60
  • 70
  • 80
  • 90
  • 100

Save Time and Resources

Office
Hysteroscopy VS
Diagnostic Hysteroscopy
In the OR

Office hysteroscopy can help decrease the rate of diagnostic hysteroscopy in the OR under anesthesia5

Cost-Effectiveness of Office Hysteroscopy - Study

Savings of
$1,498
Per Patient

75 of 130 women who underwent diagnostic office hysteroscopy for abnormal bleeding did not need to undergo hysteroscopy in the OR. This represents estimated savings of $1,498 per patient.5

Cost-Effectiveness of Office Hysteroscopy - Study

References

1. ACOG Practice Bulletin Number 128. 2. Goldstein S, Zeltser I, Horan C, et al. Am J Obstet Gynecol. 1997;177:102-108. 3. Isaacson K. Curr Opin Obstet Gynecol. 2002;14:381-385. 4. Garcia A. OBG Manage. 2013;25:44-48. 5. Moawad N, Santamaria E, Johnson M, Shuster J. JSLS. 2014;18:1-5.

"Endosee allowed myself and the patient a direct assessment of the uterine cavity. We were both surprised to see the reoccurrence and extent of intrauterine pathology that I was not able to appreciate on pelvic sonogram."

Dr. Steven R. Goldstein
  • Steven Lindhelm, MD, MMM
  • Wright State University
  • Boonshaft School of Medicine